Your institution may have access to this item. Find your institution then sign in to continue.
Title
Trifarotene (Aklief)-A New Topical Retinoid for Acne.
Abstract
This Medical Letter review summarizes mechanisms of action and evidence of effects of Aklief, a 0.005% topical cream approved in 2019 for treatment of acne vulgaris in patients aged 9 years or older.